Introduction: Bronchiectasis is a chronic endobronchial suppurative disease characterized
by irreversibly dilated bronchi damaged by repeated polymicrobial infections and …

Objective To review the airway microbiome in chronic obstructive pulmonary disease
(COPD), bronchiectasis and bronchiectasis‐COPD overlap (BCO). Data source and study …

Nontuberculous mycobacterial (NTM) pulmonary disease (PD) is an emerging condition with
heterogeneous manifestations from both the microbiological and the clinical point of view …

Chronic obstructive pulmonary disease (COPD) and bronchiectasis represent chronic
airway diseases associated with significant morbidity and mortality. Bacteria and viruses are …

Non-cystic fibrosis bronchiectasis is a chronic disorder in which immune system
dysregulation and impaired airway clearance cause mucus accumulation and consequent …

Cystic fibrosis (CF) is a chronic disease causing severe impairment to the respiratory system
and digestive tracts. Currently, CF is incurable. As an autosomal recessive disorder, the …

Objective To discuss surgery for non-cystic fibrosis [CF] bronchiectasis in children and
adolescents. Sources Non-systematic review including articles in English, mainly from the …

Background: Noncystic fibrosis bronchiectasis (NCFB) is still considered an “orphan
disease” in pediatric age. Objective: The study describes the clinical and functional features …

Non-cystic fibrosis bronchiectasis (NCFB) is a chronic respiratory disease resulting in
chronic cough, thick sputum, and lower airway microbial colonization, akin to patients with …

Rationale: The pathobiology of Staphylococcus aureus in non–cystic fibrosis bronchiectasis
(nCFB) is poorly defined. When present at high density or “inoculum,” some methicillin …